“Spesolimab Use for Generalized Pustular Psoriasis Flare Prevention in Patients with Concomitant Plaque Psoriasis: Results from the Effisayil 2 Trial” (2024) SKIN The Journal of Cutaneous Medicine, 8(2), p. s360. doi:10.25251/skin.8.supp.360.